Abstract
• Molnupiravir exhibits effective antiviral activity against ZIKV in vitro. • Intraperitoneal administration of Molnupiravir protects mice from lethal ZIKV challenge. • Molnupiravir might act on the replication phase of the ZIKV life cycle.